Heparin is cheap and essential to millions of hospitalized people. Tariffs could disrupt the supply chain that gets ...

Belief BioMed (BBM) and Takeda China have announced China’s National Medical Products Administration's (NMPA) approval for ...

The president is expected to impose tariffs on pharmaceuticals, though full details of the plan have not yet been announced.

China - Interpretation Of The Anti-Monopoly Guidelines For Pharmaceutical Sector: Key Risk Considerations. Explore the key provisions of China’s Anti-Monopoly Guidelines for the Pharmaceutical Sector, ...

In contrast, the policy is expected to disproportionately affect US chip companies with domestic wafer fabs, including Intel, ...